| Authorized generic drugs, price competition, and consumers' welfare. |
|
|
|
Authorized generic drugs, price competition, and consumers' welfare. Health Aff (Millwood). 2007 May-Jun;26(3):790-9 Authors: Berndt ER, Mortimer R, Bhattacharjya A, Parece A, Tuttle E The growing frequency of authorized generics has important implications for the welfare of prescription drug consumers. Authorized generic entry could affect the timing of generic entry, brand-name and generic prices, and generic penetration. We reviewed 1999-2003 data and found that generic entry in the absence of short-run exclusivity restrictions benefits consumers through lower short-run prices. We suggest that these benefits likely also result from authorized generics. We posit that long-run prices and shares are likely essentially unaffected by authorized generics and that potential costs to consumers from any delayed generic entry are likely small. PMID: 17485758 [PubMed - indexed for MEDLINE] Read more...             |
|||
| < Prev | Next > |
|---|